Send to

Choose Destination
Cell Cycle. 2008 Sep 1;7(17):2674-81. Epub 2008 Sep 30.

Somatic oncogenic mutations, benign skin lesions and cancer progression: where to look next?

Author information

Department of Dermatology, Hospital del Mar, Barcelona, Spain.


Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi). The same mutations have been observed in malignant neoplasms from other tissues (bladder carcinoma, cervix cancer, colorectal cancer, myeloma). However, many of the abovementioned epithelial benign cutaneous tumors do not harbour mutations in FGFR3 or PIK3CA. In this review, we focus on new candidate genes for discovery and we outline the potential of the skin as a model to achieve a better understanding of cancer biology.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center